A man collapsed in the White House on Thursday during President Donald Trump’s announcement on lowering weight loss drug prices.
Eli Lilly CEO David Ricks was speaking when the man dropped, according to a video that circulated on social media. Dr. Mehmet Oz, administrator of the Centers for Medicare & Medicaid Services, approached the man and asked him, “Gordon are you okay?”
Many speculated that the man was Gordon Findley, an executive at pharmaceutical company Novo Nordisk, but the company told the Washington Examiner that “CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office.”
The Washington Examiner contacted the White House, and the Department of Health and Human Services for confirmation on the man’s identity and status.
TRUMP MAKES DEAL TO LOWER PRICES OF OBESITY DRUGS FROM ELI LILLY AND NOVO NORDISK
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted,” White House press secretary Karoline Leavitt told the White House press pool. “The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Trump struck a deal between Eli Lilly and Novo Nordisk on selling their obesity drugs at discounted prices.
